Navigation Links
Pacific Biosciences and Harvard scientists decode genome of Haitian cholera pathogen
Date:12/10/2010

Menlo Park, Calif. December 9, 2010 Scientists from Pacific Biosciences of California, Inc. (NASDAQ: PACB) and Harvard Medical School have successfully employed single molecule, real-time (SMRT) DNA sequencing technology to rapidly characterize the pathogen responsible for the recent deadly cholera epidemic in Haiti. Published Thursday in the New England Journal of Medicine, the results provide the first whole genome sequence analysis and most detailed genetic profile to date of the Haitian Vibrio cholerae outbreak strain.

The multi-strain sequencing and bioinformatic analysis confirm that the cholera pathogen now present in Haiti is closely related to the "El Tor O1" variant from South Asia. Given that the existence of this strain has never been documented in the Caribbean region or throughout Latin America, the evidence suggests that the Haitian epidemic began as a result of the introduction of a new strain from a distant geographic source. While the sequence analysis confirms a South Asian lineage, it does not identify the specific source of the Haitian strain or suggest how it may have arrived in the country.

In this collaboration, DNA prepared from five V. cholerae strains at Harvard Medical School was received at Pacific Biosciences on Wednesday, November 10, 2010. "Through the truly remarkable and dedicated efforts of Dr. Schadt and his colleagues at PacBio, we had a good understanding of the genome of the Haitian V. cholerae isolates and their likely origin by Friday evening, November 12," said John Mekalanos, Ph.D., Chair of the Department of Microbiology and Molecular Genetics at Harvard Medical School, a senior author on the study. "This understanding has important public health policy implications for preventing cholera outbreaks in the future."

Members of a team led by Stephen Calderwood, M.D., Chief of the Division of Infectious Diseases at Massachusetts General Hospital and Morton N. Swartz M.D. Academy Professor of Medicine (Microbiology and Molecular Genetics) at Harvard Medical School, recently returned from working alongside public health experts in Haiti where they collected samples for the study in cooperation with Haitian collaborators.

"Witnessing the scale of human suffering caused by the rapidly progressing cholera outbreak, our team was compelled to deploy a technology that could immediately provide comprehensive genomic information about this virulent strain and quickly get it into the hands of the global health and research community," said Jason Harris, M.D., Physician, Pediatric Infectious Disease Unit at Massachusetts General Hospital and Assistant Professor of Pediatrics at Harvard Medical School. "In the initial stages of a major epidemic, real time is the speed we need to be working in order to have the greatest impact on saving lives."

Whole genome sequencing involves decoding the precise order of nucleotide bases that make up an organism's complete set of DNA and provides more comprehensive information than other analysis methods such as DNA fingerprinting or arrays. With advances in technology and decreasing cost, whole genome sequencing is emerging as the gold standard method for identifying and classifying infectious agents. SMRT technology is the latest advance in DNA sequencing, capable of generating long sequence reads to resolve structural variations and complex genomes at ultra-fast speeds by 'eavesdropping' on DNA replicating in real time.

"Now armed with a more complete characterization of this pathogen, the scientific community is empowered with information that can be used to inform public health policy decisions such as the appropriate use of vaccines to quell this epidemic," said Eric Schadt, Ph.D., Chief Scientific Officer of Pacific Biosciences and co-author of the paper. "The ability to quickly and easily perform real-time monitoring of pathogens also opens the door to using this technology as a routine surveillance method, for public health protection in addition to pandemic prevention and response."

To obtain a comprehensive genomic characterization of the origin of the Haitian cholera pathogen, the PacBio/Harvard team sequenced two samples from the current Haiti outbreak, two samples from South Asia (Bangladeshi isolates from 1971 and 2008), and one sample from Latin America (a 1991 Peruvian isolate). The team then compared this high resolution whole genome sequence information to DNA sequence information available in public databases for 23 diverse strains of V. cholerae.


'/>"/>

Contact: Nicole Litchfield
Nicole@bioscribe.com
415-793-6468
Bioscribe
Source:Eurekalert

Related biology technology :

1. CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries
2. Quintiles Expands Base for Growing Asia-Pacific Operations
3. Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008
4. PacificGMP and Actinium Pharmaceuticals Announce Agreements for cGMP Antibody Manufacturing and Stability Testing
5. Pacific Northwest National Laboratories Becomes a GeneGo Center of Excellence
6. Queensland Facility for Advanced Bioinformatics (QFAB) Becomes a GeneGo Center of Excellence for the Asia Pacific Region
7. PacificGMP and LigoCyte Pharmaceuticals Announce cGMP Manufacturing Collaboration
8. Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List
9. Copan Announces the Appointment of Bob Cooper as Vice President of Business Development in the Pacific Rim
10. OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific
11. Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan. 18, 2017  Market Research Future published a ... Market is expected to grow at a CAGR of 12% during ... ... caused due to the abnormal cell division without any control. These ... harm to them. These cancer cells can spread to other parts ...
(Date:1/17/2017)... , Jan. 17, 2017 Roka Bioscience, Inc. (NASDAQ: ... testing solutions for the detection of foodborne pathogens today announced the ... Duseau succeeds Paul Thomas , the Company,s President and CEO ... Company,s Board of Directors.  The changes are effective today. ... effective today. ...
(Date:1/17/2017)... Jan. 17, 2017  Only nine percent of U.S. ... profits, while only 16 percent believe health insurance companies ... Meanwhile, 36 percent of U.S. adults believe health care ... profits, compared to hospitals (23%). "We are ... Wendy Salomon , vice president of reputation management ...
(Date:1/17/2017)... and Hong Kong (PRWEB) , ... January 17, ... ... lifecycle management software, and NetDimensions, a global provider of learning and performance management ... agreement for the mainland China market. , “In the life sciences industry, organizations ...
Breaking Biology Technology:
(Date:1/6/2017)...  SomaLogic announced today that it has agreed ... iCarbonX, the China -based company ... Health Ecosystem that can define each person,s ,digital ... behavioral and psychological data, the Internet and artificial ... will provide proteomics data and applications expertise to ...
(Date:1/4/2017)... 4, 2017  CES 2017 – Valencell , ... today announced the launch of two new versions ... highly-accurate biometric sensor modules that incorporate the best ... and expertise. The two new designs include Benchmark ... hearables, and Benchmark BW2.0, a 2-LED version of ...
(Date:12/22/2016)... NEW YORK , December 22, 2016 ... global provider of secure solutions for the e-Government, Public Safety, HealthCare, ... a subsidiary of SuperCom, has been selected to implement and deploy ... county in Northern California , further expanding its ... ...
Breaking Biology News(10 mins):